Indicator Explainer
KRAS Gene
This gene is involved in signal transduction and apoptosis.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C25785. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-18. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
References
- NCI Thesaurus 26.09d — KRAS Gene (C25785)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C25785. NCI definition, reproduced without modification under CC BY 4.0.
- Association between KRAS gene mutation and clinicopathological factors in patients with metastatic colorectal cancer. — Arq Bras Cir Dig, 2026-10-05 (PMID 42848681; literature)
- MCKG-SL: Knowledge graph-based multi-feature cross-aggregation synthetic lethality prediction for KRAS gene. — Artif Intell Med, 2026-09-10 (PMID 42721585; literature)
- The Long, Remarkable History of KRAS and Pancreatic Cancer: From Gene Discovery to Successful Therapeutic Targeting. — Mod Pathol, 2026-08-05 (PMID 42556473; literature)